Li, Jia http://orcid.org/0000-0002-5931-3058
Lu, Mei
Zhou, Yueren
Bowlus, Christopher L.
Lindor, Keith
Rodriguez-Watson, Carla
Romanelli, Robert J.
Haller, Irina V.
Anderson, Heather
VanWormer, Jeffrey J.
Boscarino, Joseph A.
Schmidt, Mark A.
Daida, Yihe G.
Sahota, Amandeep
Vincent, Jennifer
Wu, Kuan-Han Hank
Trudeau, Sheri
Rupp, Loralee B.
Melkonian, Christina
Gordon, Stuart C.
,
Funding for this research was provided by:
Intercept Pharmaceuticals
Article History
Received: 19 February 2021
Accepted: 5 August 2021
First Online: 9 September 2021
Declarations
:
: Stuart C. Gordon receives grant/research support from AbbVie Pharmaceuticals, Conatus, CymaBay, Gilead Pharmaceuticals, Intercept Pharmaceuticals, and Merck. Mei Lu, Jia Li, Lora Rupp, Sheri Trudeau, Yueren Zhou, Christina Melkonian, Yihe G. Daida, Mark A. Schmidt, and Joseph A. Boscarino receive grant/research support from Gilead Pharmaceuticals. Carla V. Rodriguez owns stock in Gilead (< $5,000). Heather Anderson receives grant/research support from Intercept Pharmaceuticals. Jeffrey J. VanWormer receives grant/research support from Retrophin. Christopher L. Bowlus receives grant/research support from AbbVie Pharmaceuticals, Bristol-Myers-Squibb, Gilead Biosciences, Intercept Pharmaceuticals, Merck, Shire Pharmaceuticals, Takeda Pharmaceuticals, and has served as an advisor for Bristol-Myers-Squibb, Gilead Biosciences, Intercept Pharmaceuticals, and Takeda. Keith Lindor is a consultant/advisor for Biopharma and has served as an ad hoc advisor for HighTide, Takeda, Shire, and Intercept Pharmaceuticals. He sits on a Data Safety Monitoring Board for Takeda. Robert J. Romanelli receives received grant/research support from Pfizer Inc. and Janssen Scientific Affairs. Irina V. Haller, Marsha A. Raebel, and Jennifer Vincent have no conflicts of interest to declare.